Phibro Animal Health Corporation
PAHC:US US71742Q1067
Key Information
HQ:
United States
Market Cap:
$0.77bn
Primary Market:
North America
Animal Pharmaceuticals Engagement
Analysis Breakdown
Sales and Marketing Practices
Strategy, risk and reporting on antibiotics
NRD
Applying a consistent sales and marketing approach in line with best practice operating market
NRD
Manufacturing and Production
Demonstrating effective management of antibiotic residues in manufacturing and production
NRD
Research and Development
Defining alternatives to antibiotics
Low
Increasing availability and use of alternatives to antibiotics
NRD
Stakeholder Engagement and Lobbying
Stewardship initiatives
NRD
Lobbying and political expenditure
NRD
Company Engagement
Level of company engagement with the coalition
Inactive
Workstream Information
Last Updated:
22nd May 2023
2022/23 Resources
Phibro Assessment
Investor Briefing Pack
Sample Engagement Letter
Key Findings Report
Progress Report
Engagement Progress Report Webinar Video
Animal Pharmaceuticals Engagement